Press

Press and
Media Center.

AXIONOVA is a precision bio-science and longevity platform for practitioners, clinics, and qualified healthcare organizations. Media and partner requests are routed for human review before publication.

Hi, I am ALETHA. I help you understand your data and prepare it for your practitioner. I do not make clinical decisions; your practitioner does.

ALETHRA governs; ALETHA guides. The governance model

About AXIONOVA for Journalists

Precision bio-science,
governed for human optimization.

AXIONOVA develops physician-directed biological systems that connect compound identity, protocol logic, governed delivery (AXIS), and continuous physiology (AXIONOVA Ring and Bracelet) into one controlled model. ALETHRA governs the system. ALETHA guides the experience. Learn more

Regulatory note · AXIONOVA compounds and related materials are compounded medications prepared by licensed pharmacies pursuant to valid prescriptions. Compounded medications are not FDA-approved. All clinical decisions are made by licensed physicians.

Media Requests

Routed for human review
before publication.

A human team reviews every media inquiry before any statement is published. AXIONOVA does not authorize disease, therapeutic, or performance claims, and public statements stay within physician-directed compliance boundaries.

Communications · Powered by ALETHRA

Transparency in system governance.

Press communications are logged under ALETHRA for provenance and audit. Reach the communications office directly.